Tolulope’s expertise is in intellectual property law and public health law. His research focuses on the role of intellectual property law in vaccine development and distribution. More generally, he is interested in issues pertaining to facilitating access to vaccines and other medical technologies on equitable and affordable terms. He completed his PhD at the City University of Hong Kong, which was funded by the University Grants Committee of Hong Kong and the Max Planck Institute for Innovation and Competition in Germany. After completing his doctoral research, he worked as a postdoctoral research fellow at the Faculty of Law, Chinese University of Hong Kong, and the Max Planck Institute for Innovation and Competition. He holds a German and European Law Certificate from the Ludwig Maximilian University of Munich, Germany, and is qualified as a Barrister and Solicitor of the Supreme Court of Nigeria. He is currently a consultant to the South African Research Chair in Industrial Development, University of Johannesburg, and the United Nations Office of the Special Adviser on Africa. He is also an affiliate fellow at the Information Society Law Center of the University of Milan, Italy and the Centre for Policy Futures University of Queensland. Among other past experiences, he has held teaching positions at the City University of Hong Kong and Landmark University, Nigeria.
Adekola, Tolulope Anthony (2023). Regional cooperation, intellectual property law and access to medicines: a holistic approach for least developed countries. London, United Kingdom: Routledge. doi: 10.4324/9781003342519
Journal Article: Human rights law, intellectual property and vaccine nationalism: lessons for the post-COVID-19 world
Adekola, Tolulope Anthony and Majekolagbe, Faith O. (2023). Human rights law, intellectual property and vaccine nationalism: lessons for the post-COVID-19 world. Australian Journal of Human Rights, ahead-of-print (ahead-of-print), 1-19. doi: 10.1080/1323238X.2023.2286941
Journal Article: When mRNA technology meets patent law: innovation, barriers and public health
Adekola, Tolulope Anthony (2023). When mRNA technology meets patent law: innovation, barriers and public health. Journal of Intellectual Property Law and Practice, 18 (12), 867-877. doi: 10.1093/jiplp/jpad086
Adekola, Tolulope Anthony (2023). Regional cooperation, intellectual property law and access to medicines: a holistic approach for least developed countries. London, United Kingdom: Routledge. doi: 10.4324/9781003342519
Human rights law, intellectual property and vaccine nationalism: lessons for the post-COVID-19 world
Adekola, Tolulope Anthony and Majekolagbe, Faith O. (2023). Human rights law, intellectual property and vaccine nationalism: lessons for the post-COVID-19 world. Australian Journal of Human Rights, ahead-of-print (ahead-of-print), 1-19. doi: 10.1080/1323238X.2023.2286941
When mRNA technology meets patent law: innovation, barriers and public health
Adekola, Tolulope Anthony (2023). When mRNA technology meets patent law: innovation, barriers and public health. Journal of Intellectual Property Law and Practice, 18 (12), 867-877. doi: 10.1093/jiplp/jpad086
Pharmaceutical patent law and policy in Africa: a survey of selected SADC member states
Mercurio, Bryan, Adekola, Tolulope Anthony and Tsega, Chimdessa Fekadu (2023). Pharmaceutical patent law and policy in Africa: a survey of selected SADC member states. Legal Studies, 43 (2), 331-350. doi: 10.1017/lst.2022.43
Adekola, Tolulope Anthony (2022). Compulsory licences in a regional context: an appraisal of the TRIPS amendment’s special regional treatment. GRUR International, 71 (9), 822-830. doi: 10.1093/grurint/ikac075
Investment robo-advisors: some reflections on China's regulatory experience
Xiao, Shanyun and Adekola, Tolulope Anthony (2021). Investment robo-advisors: some reflections on China's regulatory experience. Banking and Finance Law Review, 37 (1), 127-148.
Adekola, Tolulope Anthony (2020). Should COVID-19 treatment be patented? Rethinking the theoretical justification for the grant of pharmaceutical patent. European Intellectual Property Review, 42 (11), 695-697.
Revisiting the public health implications of the United States-Mexico-Canada agreement
Adekola, Tolulope Anthony (2020). Revisiting the public health implications of the United States-Mexico-Canada agreement. Globalization and Health, 16 (1) 50, 1-2. doi: 10.1186/s12992-020-00579-y
Intellectual Property and Access to Medicines in Africa: A Regional Framework for Access
Adekola, Tolulope Anthony (2020). Intellectual Property and Access to Medicines in Africa: A Regional Framework for Access. Queen Mary Journal of Intellectual Property, 10 (2), 269-270. doi: 10.4337/qmjip.2020.02.08
Has the Doha paragraph 6 system reached its limits?
Adekola, Tolulope Anthony (2020). Has the Doha paragraph 6 system reached its limits?. Journal of Intellectual Property Law and Practice, 15 (7), 525-529. doi: 10.1093/jiplp/jpaa058
Adekola, Tolulope Anthony (2020). Regional mechanism under DOHA Paragraph 6 system: the largely untested alternative route for access to patented medicines. Asian Journal of Wto & International Health Law and Policy, 15 (1), 61-90.
US–China trade war and the WTO dispute settlement mechanism
Adekola, Tolulope Anthony (2019). US–China trade war and the WTO dispute settlement mechanism. Journal of International Trade Law and Policy, 18 (3), 125-135. doi: 10.1108/JITLP-02-2019-0011
Adekola, T. A. (2019). Public health–oriented intellectual property and trade policies in Africa and the regional mechanism under Trade-Related Aspects of Intellectual Property Rights amendment. Public Health, 173, 1-4. doi: 10.1016/j.puhe.2019.04.019
Adekola, Tolulope Anthony (2019). Abolition of graphical representation in EU trademark directive: should countries with similar provisions follow EU’s footsteps?. Journal of Intellectual Property Rights, 24 (3-4), 62-68.
Adekola Tolulope Anthony (2023). The bourgeoning mRNA technology patent landscape - implications for innovation and concerns regarding technology underutilisation. The Fifth IP and Innovation Researchers of Asia (IPIRA) Conference, Singapore, 1-3 March 2023.
Adekola Tolulope Anthony (2022). COVID-19 and beyond: recalibrating Africa's use of TRIPS flexibilities for sustainable pharmaceutical access. Munich, Germany: Max Planck Institute for Innovation and Competition.